Ruben A. Mesa, M.D., FACP

Dr. Mesa is president at Enterprise Cancer Service Line Atrium Health and executive director of the NCI Comprehensive Cancer Center at Atrium Health Wake Forest Baptist Medical center. Dr. Mesa is also the Vice Dean for Cancer at Wake Forest School of Medicine. Dr. Mesa has been principal investigator or co-principal investigator in more than 100 clinical trials for patients with myeloid disorders and played a lead role in various FDA approvals. He has been a funded investigator of the National Cancer Institute (NCI) on several projects in myeloproliferative neoplasms and is appointed to the NCI Clinical Trial Advisory Committee. Dr. Mesa plays a range of leadership roles with the American Society of Hematology and elected to the Board of the American Association of Cancer Institutes. Dr. Mesa completed his undergraduate training in nuclear engineering and physiology at University of Illinois and attended Mayo Medical School in Rochester, MN, where he completed his internal medicine residency and hematology & medical oncology fellowship. He was then on the faculty of the Mayo Clinic in hematology and later served as deputy director of the Mayo Clinic Cancer Center from 2012-2017, and executive Director of the NCI Designated Mays Cancer Center in San Antonio from 2017-2023.